Prothena (PRTA) 10-K2017 FY Annual report

Filed: 26 Feb 18, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: acknowledged, amyotrophic, arm, assay, Baylor, Belgium, beta, Biomedicine, Brazil, breakdown, Bulletin, Burnham, cardiomyocyte, cardiotoxicity, catalytic, censored, CHF, clock, codified, concomitant, condensed, Conference, CTE, dcurtailment, de, devastating, downstream, driven, elevation, elucidated, encephalopathy, error, Escola, EudraCT, exhibited, extracellular, frontotemporal, FTD, GDPR, gender, Germany, grave, hATTR, heme, HFSA, HITECH, imaging, immunoglobulin, implicated, influence, inhibit, interdependent, intrusion, Jankovic, Joseph, Lastly, MAA, marker, mechanistic, Medicina, Merlini, mg, NCT, Neuropathology, neuroprotective, neuroscience, oxidative, palsy, PASADENA, Paulista, Paulo, PCAOB, pharmacodynamic, pronouncement, provisional, proximity, PSP, relevantly, relocate, relocation, remeasurement, repeal, SAB, Sao, SE, slower, Spain, supersede, supranuclear, tau, TCJA, traumatic, Universidade, Wagner, week, Zago, Zug

Removed: abnormal, advice, agreed, alpha, annum, anxiety, API, auditing, autoimmune, autoinflammatory, Baltimore, book, broader, calculation, calendar, cervical, complicating, constrain, create, credited, depression, diminished, disproportionately, driver, DSMB, dystonia, enrolling, entail, epidemiology, ESOL, execution, existed, expired, explore, externally, fight, Franklin, growing, headcount, hematological, historically, Houston, identification, immune, immunosuppressive, improve, inappropriate, inform, interpreting, Koller, labor, leave, Marshall, Martin, Maryland, MCAM, MD, medium, melanoma, migraine, migrate, MPH, nationalized, NDA, neurologist, November, occupied, optimal, pathogen, penalty, pertinent, pivotal, preempted, promulgated, propagation, pure, RDSA, reflective, reliable, representative, Science, scientifically, sized, solid, Sonexa, standalone, stroke, subscription, surface, tolerance, toxicology, transmit, traveling, uncovered, wall, weaken, wholly

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated PRTA transcripts

PRTA similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

The Board of Directors

Prothena Corporation plc:

We consent to the incorporation by reference in the registration statements (Nos. 333-218184, 333-211653, 333-196572 and 333-187726) on Form S-8 and the registration statements (Nos. 333‑203258, 333-197006, 333-196965 and 333-193416) on Form S-3 of Prothena Corporation plc of our reports dated February 23, 2018 with respect to the consolidated balance sheets of Prothena Corporation plc as of December 31, 2017 and 2016, and the related consolidated statements of operations, shareholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2017, and the related notes (collectively, the “consolidated financial statements”), and the effectiveness of internal control over financial reporting as of December 31, 2017, which reports appear in the December 31, 2017 annual report on Form 10‑K of Prothena Corporation plc.

/s/ KPMG LLP

San Francisco, California

February 23, 2018